SCHEMBL5186751

SCHEMBL5186751

CC(C)N1C[C@@H](N)[C@H](c2ccc(Br)cc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 9/20 0.53
MAOB P27338 5/20 0.53
KCNH2 Q12809 2/20 0.53
RCOR1 Q9UKL0 2/20 0.53
KDM1B Q8NB78 1/20 0.53
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
MAOA P21397 3/20 0.36
GRIA4 P48058 2/20 0.36
RORC P51449 2/20 0.36
GRIA2 P42262 1/20 0.36
BRD4 O60885 1/20 0.36
MDM2 Q00987 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
THPO P40225 1/20 0.36
CYP2B6 P20813 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5186744 1.00 KDM1A (0.53) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL5186738 1.00 KDM1A (0.53) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL18022013 0.84 MAOB (0.52) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL22962229 0.84 MAOB (0.52) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL5187998 0.79 KDM1A (0.57) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL5187993 0.79 KDM1A (0.57) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL5188008 0.79 KDM1A (0.57) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL19459218 0.78 BRD4 (0.47) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL5184995 0.75 KDM1A (0.52) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL5184999 0.75 KDM1A (0.52) KDM1AMAOBKCNH2RCOR1KDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070270471-A1 Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine GLAXO GROUP LIMITED (GB) 2007-11-22 US disclosed
EP-1786769-A1 COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE GLAXO GROUP LIMITED (GB) 2007-05-23 EP disclosed
WO-2006015827-A1 COMPOUNDS WHICH POTENTIATE GLUTAMATE RECEPTOR AND USES THEREOF IN MEDICINE GLAXO GROUP LIMITED (GB) 2006-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270471-A1 Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine GRM3, GLRA3, GLRA1 KDM1A 3089/4885MAOB 1272/4885KCNH2 562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.